2024-513393-22-00招募中1 期
Effect of Renal Impairment on Enpatoran Pharmacokinetics
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Global Regulatory Affairs
Scientific
Merck Healthcare KGaA
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants2024-512841-17-00Merck Healthcare KGaA40
已完成
1 期
Effect of Renal Impairment on Enpatoran PharmacokineticsRenal ImpairmentNCT06589713Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany34
招募中
4 期
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart FailureChronic Kidney DiseaseNCT07259512Evi Liliek Wulandari80
招募中
3 期
Effectiveness and Safety of Sparsentan as treatment for Immunoglobulin A Nephropathy (IgAN)2023-505495-30-00Travere Therapeutics Inc.162
招募中
4 期
Evolution of proteinuria in renal transplant patients treated with Dapagliflozinchronic renal failure2023-506295-26-00University Hospital Of Montpellier70